Sign in to view content

Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial

Rajiv Anand, MD, FRCS, FASRS

Video
Published 2024

Related

Retinitis Pigmentosa
Ginny Martinez
Retina Image Bank: Images of the Week
2017
Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial
Anthony Joseph, MD
Annual Meeting Talks
2020
Is the Choroid Driving the Development of Cystoid Macular Edema in Eyes With Retinitis Pigmentosa?
David Sarraf, MD
Annual Meeting Talks
2019

Category: Hereditary Retinal Disease & Genetics

See more